Maravai LifeSciences Holdings Inc.
10/27/2025 | Press release | Distributed by Public on 10/27/2025 14:24
Management Change/Compensation (Form 8-K)
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On October 21, 2025, as part of Maravai LifeSciences Holdings, Inc.'s (the "Company") efforts to rationalize the size of its Board of Directors (the "Board") and reduce administrative costs, Benjamin Daverman, Jessica Hopfield, PhD, and Murali Prahalad, PhD each agreed to voluntarily resign from the Board effective as of the close of business on such date (the "Effective Date"). In connection with their resignations, the Board reduced its size from eleven (11) to eight (8) directors, effective as of October 27, 2025. None of the resignations were related to any disagreement with the Company's management, the Board or any committee of the Board on any matter related to the Company's operations, policies or practices. The Company expresses its sincere thanks to Mr. Daverman, Dr. Hopfield, and Dr. Prahalad for their service on the Board and valuable contributions to the Company.
Effective upon Dr. Hopfield's and Dr. Prahalad's resignations from the Board, (i) R. Andrew Eckert was appointed chair of the Nominating, Governance and Risk Committee and as a member of the Audit Committee and (ii) Gregory T. Lucier was appointed as a member of the Nominating, Governance and Risk Committee.
In recognition of the departing directors' past service on the Board, the Board accelerated the vesting of all unvested restricted stock unit awards held by the departing directors effective as of the Effective Date.
Maravai LifeSciences Holdings Inc. published this content on October 27, 2025, and is solely responsible for the information contained herein. Distributed via Edgar on October 27, 2025 at 20:24 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]